Novel polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding said polypeptides, and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.

 
Web www.patentalert.com

< Control of weed with a fungal pathogen

> EGFR inhibitors promote axon regeneration

~ 00468